Every year, IBO selects a firm from our industry as Company of the Year. This designation is based on IBO’s recognition that the selected analytical instrument maker has accomplished significant technical, operational and financial achievements during the year. Such achievements are measured by financial performance, market leadership, product introductions and key strategic investments. IBO’s 2010 […]
Chemicals The chemical industry bounced back in 2010, as Asian demand and higher prices led to decreased capacity and higher profitability. According to the American Chemical Council (ACC), chemical production volumes improved 8.8% last year (see IBO 12/15/10), driven by a 12.2% increase in emerging markets. Oxford Economics estimates worldwide production of chemicals and man-made […]
Now that 2010 has come to an end on a high note, it is time to look ahead to the coming year and the prospects for the analytical and life science instrument industry. Based on the trends that have been seen during the last half year, it is safe to say 2011 will be a […]
In each year’s forecast issue, IBO takes a look back at the events of the previous year and the trends that emerged. The list is presented in no particular order. Recovery Last year was a year of recovery for analytical instrument and laboratory product sales. On the heels of the global economic upturn, instrument sales […]
Company Announcements Staffan Lindstrand, partner at HealthCap, resigned from Biotage’s Board in October. HealthCap sold its shares in Biotage in August. In November, Waters launched the Centers of Innovation Program to support scientific innovation in the fields of health and life science research, sports science, food safety, clinical research and environmental protection. The company announced […]
In a blow to UK science, the Department for Business, Innovation and Skills has announced the budgets for university research for upcoming fiscal years (see IBO 10/31/10). Funding for science and research programs has been “ringfenced.” Instead, capital funding will bear the brunt of spending cuts. “We shall delay capital investment to maximize investment in […]
A new US food safety bill signed into law this month will increase FDA authority over the US food supply and increase the application of scientific standards to food safety. The Food Safety Modernization Act is the country’s first major food legislation since 1938. The Act is expected to be signed by President Obama early […]
In 2010, the US economy and equity markets sustained a strong recovery in the wake of the financial collapse two years ago. Following double-digit gains in 2009, the Dow Jones Industrial Average, S&P 500 and NASDAQ added 11.0%, 12.8% and 16.9% in 2010, respectively. Equity prices benefited from monetary stimulus, improving macroeconomic data, strong corporate […]
Due to the IBO’s January 15 forecast issue, third-quarter results for the Lab Equipment/Consumables Sales Index are included in this issue. Index sales grew 2.7%, 3.6% excluding currency, to $3,760.20 million. Operating profits improved 3.2% to $631.67 million, and adjusted operating margins were unchanged at 17.2% of sales. For the fiscal first quarter ending October […]
Third-quarter 2010 IBO Life Science Index sales grew 7.2%, 8.5% excluding currency, to $2,944.55 million. Operating profit improved 11.5% to $636.50 million, and operating margin gained 110 basis points to 22.5% of sales. Third-quarter revenue for Beckman Coulter’s Life Sciences segment declined 5.1%, 4.1% at constant currency, to $106.1 million to account for 12% of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
